Effect of TECAR therapy and neurodynamic techniques in treatment of carpal tunnel syndrome.

The effectiveness of TECAR therapy and neurodynamic techniques VS. neurodynamic techniques and placebo TECAR on pain and function in subjects with carpal tunnel syndrome.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20191208045652N3

Enrollment

Registered

2021-03-18

Start date

2021-01-19

Completion date

Unknown

Last updated

2021-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carpal Tunnel Syndrome. Carpal tunnel syndrome

Interventions

Intervention 1: In this study, TECAR (winback made in France) is used. The frequency used is 300 kHz which is selected due to the use of metal electrodes and the lack of high heat and burns. The patie

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Patients with age range of 18-60 years ol Pain and paresthesia in at least 2 fingers of 3/5 lateral fingers for 1-6 months. Diagnosis of CTS based on EMG tests (distal motor latency>4m.s and distal sensory latency >5/3 m.s) Positive Phalen and Tinel test Ability to read and write in Persian

Exclusion criteria

Exclusion criteria: pregnancy Thenar atrophy history of any hand or wrist surgery Metabolic diseases (Diabetes mellitus, thyroid or kidney problem) cervical radiculopathy Fibromyalgia or other musculoskeletal disorders Any history of severe trauma to the wrist and Connective tissue disorders Patient dissatisfaction with the continuation of the treatment and evaluation process

Design outcomes

Primary

Measure	Time frame
Pain. Timepoint: At the beginning and the end of each session and two months after the end of the last treatment session. Method of measurement: visual analogue scale.	—

Secondary

Measure	Time frame
Grip strength. Timepoint: At the beginning and the end of each session and two months after the end of the last treatment session. Method of measurement: Hand held dynamo meter.;Functional status scale of Boston questionnaire. Timepoint: Before treatment, at the end of third session and two months after the end of the last treatment session. Method of measurement: Persian Boston Questionnaire.;Symptom severity scale of Boston Questionnaire. Timepoint: Before treatment, at the end of third session and two months after the end of the last treatment session. Method of measurement: Persian Boston Questionnaire.	—

Measure

Time frame

Grip strength. Timepoint: At the beginning and the end of each session and two months after the end of the last treatment session. Method of measurement: Hand held dynamo meter.;Functional status scale of Boston questionnaire. Timepoint: Before treatment, at the end of third session and two months after the end of the last treatment session. Method of measurement: Persian Boston Questionnaire.;Symptom severity scale of Boston Questionnaire. Timepoint: Before treatment, at the end of third session and two months after the end of the last treatment session. Method of measurement: Persian Boston Questionnaire.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSeyyede Elnaz Hashemi

Iran University of Medical Sciences

eli.hshmi@gmail.com+98 21 2222 2059

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026